The growth of Viagra and its impact on the pharmaceutical landscape presents a intricate question for shareholders. While the early sales statistics were impressive, the exclusivity has lapsed, leading to a deluge of https://gerardcbwd409034.blogginaway.com/42151290/the-blue-pill-and-big-pharma-a-risky-investment